01-676-668
West Nile Virus Envelope Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 01-676-668-Each-of-1 | In Stock | ₹ 49,706.50 |
01-676-668 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 49,706.50
GST (18%): ₹ 8,947.17
Total Price: ₹ 58,653.67
Antigen
West Nile Virus Envelope
Classification
Polyclonal
Conjugate
Unconjugated
Gene Alias
West Nile envelope; West Nile Virus; WNV envelope
Immunogen
Synthetic peptide corresponding to residues C(73) P T M G E A H N E K R A D(86) of West Nile virus envelope glycoprotein.
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.05% sodium azide
Host Species
Rabbit
Purification Method
Protein G
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Suggested positive control: West Nile virus infected cell line
- West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St
- Louis encephalitis virus, yellow fever virus, and Dengue virus
- WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe
- It has rapidly spread across the United States with cases being observed in every continental state
- Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells
- The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation.